| 000 | 01597 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515031239.0 | ||
| 264 | 0 | _c20070104 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/annonc/mdl120 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiedinger, J M | |
| 245 | 0 | 0 |
_aCA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2006 |
||
| 300 |
_a1234-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aCA-125 Antigen _xanalysis |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWafflart, J | |
| 700 | 1 | _aRicolleau, G | |
| 700 | 1 | _aEche, N | |
| 700 | 1 | _aLarbre, H | |
| 700 | 1 | _aBasuyau, J P | |
| 700 | 1 | _aDalifard, I | |
| 700 | 1 | _aHacene, K | |
| 700 | 1 | _aPichon, M F | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 17 _gno. 8 _gp. 1234-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdl120 _zAvailable from publisher's website |
| 999 |
_c16362109 _d16362109 |
||